Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 92.07%280.8M | -46.41%85.8M | -3.63%74.3M | 237.50%486M | 46.78%102.6M | 289.87%146.2M | 590.09%160.1M | 475.37%77.1M | -44.10%144M | 429.55%69.9M |
| Net income from continuing operations | -74.24%155.2M | -7.14%85.9M | -24.64%46.5M | 769.54%847.8M | 1,298.68%91.1M | 75,412.50%602.5M | -2.84%92.5M | 476.64%61.7M | 367.86%97.5M | -3,700.00%-7.6M |
| Operating gains losses | 115.98%2.7M | -562.16%-24.5M | 60.00%-1.4M | 71.37%-43.4M | 54.59%-19.3M | ---16.9M | 96.78%-3.7M | 31.37%-3.5M | -11,561.54%-151.6M | 1.62%-42.5M |
| Depreciation and amortization | 78.12%109.9M | 74.31%95M | 28.34%79.7M | 24.04%275M | 27.74%96.7M | 13.63%61.7M | 15.22%54.5M | 39.86%62.1M | -8.39%221.7M | 72.05%75.7M |
| Asset impairment expenditure | 103.51%16.1M | -80.00%1.3M | -75.00%600K | -7,152.54%-416.1M | 474.58%33.9M | ---458.9M | --6.5M | 166.67%2.4M | -71.08%5.9M | -55.97%5.9M |
| Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | ---27.3M | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -10.53%1.7M | -16.67%1.5M | 342.86%3.1M | -8.06%5.7M | --1.3M | --1.9M | --1.8M | -12.50%700K | 21.57%6.2M | ---- |
| Deferred tax | 42.31%44.4M | 113.82%78.9M | 45.19%39.2M | 321.50%129.4M | 3,018.18%34.3M | 660.98%31.2M | 118.34%36.9M | 213.95%27M | -60.69%30.7M | -90.00%1.1M |
| Other non cashItems | 186.90%19.9M | -8,000.00%-48.6M | -647.13%-47.6M | -562.99%-142.6M | -548.25%-128.2M | -432.56%-22.9M | -106.45%-600K | 35.94%8.7M | -46.71%30.8M | 57.14%28.6M |
| Change In working capital | 101.33%200K | -356.04%-41.5M | 53.42%-30.6M | -667.79%-114.4M | -238.20%-24.6M | -282.93%-15M | -750.00%-9.1M | -55.32%-65.7M | 63.30%-14.9M | 174.48%17.8M |
| -Change in receivables | 200.00%18.3M | -262.78%-29.3M | 25.00%-18.3M | -353.33%-45.6M | -5.56%-20.9M | -191.50%-18.3M | --18M | -617.65%-24.4M | 148.78%18M | 36.74%-19.8M |
| -Change in inventory | -48.62%-26.9M | -60.66%-19.6M | -2,712.50%-22.5M | 32.90%-51.4M | -86.24%-20.3M | 35.13%-18.1M | ---12.2M | 94.59%-800K | -134.97%-76.6M | -39.74%-10.9M |
| -Change in payables and accrued expense | -58.88%8.8M | 149.66%7.4M | 125.19%10.2M | -139.82%-17.4M | -65.77%16.6M | 32.92%21.4M | ---14.9M | -68.05%-40.5M | 51.21%43.7M | 219.08%48.5M |
| Tax refund paid | -586.14%-69.3M | -232.62%-62.2M | 8.98%-15.2M | 32.69%-55.4M | 35.29%-9.9M | 57.92%-10.1M | 41.56%-18.7M | -51.82%-16.7M | -21.93%-82.3M | -75.86%-15.3M |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 0 | -89.81%15.4M | 0 | |||
| Operating cash flow | 92.07%280.8M | -46.41%85.8M | -3.63%74.3M | 204.89%486M | 46.78%102.6M | 289.87%146.2M | 590.09%160.1M | 167.71%77.1M | -61.00%159.4M | 4.64%69.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 37.28%-68.8M | 68.51%-64.8M | 47.32%-86.6M | -47.78%-582.4M | 62.34%-102.5M | 53.67%-109.7M | -281.82%-205.8M | -197.39%-164.4M | 48.23%-394.1M | -33.04%-272.2M |
| Capital expenditure reported | 40.41%-66.5M | 53.96%-80.2M | 57.55%-64.9M | 38.32%-559.6M | 51.89%-120.9M | 51.54%-111.6M | 17.28%-174.2M | 28.92%-152.9M | -21.85%-907.3M | -33.53%-251.3M |
| Net PPE purchase and sale | ---- | ---- | ---- | -81.93%35.5M | 14.89%35.5M | --0 | --0 | ---- | --196.5M | --30.9M |
| Net intangibles purchas and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | --0 | --0 | -2,933.33%-18.2M | --0 | --0 | --0 | --0 | -100.16%-600K | 55,700.00%389.2M | --0 |
| Net investment purchase and sale | 6.45%3.3M | 157.58%8.5M | -116.67%-100K | 2,150.00%8.2M | --1.2M | --3.1M | --3.3M | --600K | -101.06%-400K | ---- |
| Interest received (cash flow from investment activities) | -69.81%1.6M | -19.35%2.5M | 71.79%-3.3M | -31.18%18.1M | --5.5M | --5.3M | --3.1M | -1,362.50%-11.7M | 213.10%26.3M | ---- |
| Net other investing changes | -10.77%-7.2M | 111.58%4.4M | -150.00%-100K | 14.02%-84.6M | 69.37%-23.8M | 0.00%-6.5M | -224.79%-38M | 111.76%200K | -58.20%-98.4M | -139.08%-77.7M |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 0 | 93.73%-8.2M | 0 | |||
| Investing cash flow | 37.28%-68.8M | 68.51%-64.8M | 47.32%-86.6M | -44.77%-582.4M | 62.34%-102.5M | 53.67%-109.7M | -281.82%-205.8M | -202.37%-164.4M | 54.89%-402.3M | -16.67%-272.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -3,468.57%-124.9M | -147.14%-126.1M | -276.76%-25.1M | -59.11%83.3M | -1,253.25%-194.9M | -170.00%-3.5M | 8.65%267.5M | 122.05%14.2M | -51.60%203.7M | -75.33%16.9M |
| Net issuance payments of debt | -1,653.13%-112.2M | 548.57%31.4M | ---17.5M | 313.05%194.3M | 1,501.97%213.1M | ---6.4M | -103.91%-7M | --0 | -120.04%-91.2M | -119.54%-15.2M |
| Net common stock issuance | --0 | --0 | 16.95%6.9M | --293.4M | --0 | --0 | --287.5M | --5.9M | --0 | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | -76.00%600K | -90.91%200K | --2.3M | 1,425.00%6.1M | --1.4M | --2.5M | --2.2M | ---- | --400K | ---- |
| Interest paid (cash flow from financing activities) | -1,000.00%-12.1M | ---25.9M | ---14M | ---13.8M | ---12.7M | ---1.1M | --0 | --0 | --0 | ---- |
| Net other financing activities | -180.00%-1.2M | -767.11%-131.8M | -119.72%-2.8M | -234.70%-396.7M | -1,322.08%-387.4M | -70.00%1.5M | -122.62%-15.2M | -92.68%14.2M | 963.64%294.5M | 481.93%31.7M |
| Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 88.17%-2M | 0 | |||
| Financing cash flow | -3,468.57%-124.9M | -147.14%-126.1M | -276.76%-25.1M | -58.70%83.3M | -1,253.25%-194.9M | -170.00%-3.5M | 8.65%267.5M | 121.39%14.2M | -50.07%201.7M | -73.68%16.9M |
| Net cash flow | ||||||||||
| Beginning cash position | -56.24%223.8M | 8.72%316.6M | -5.34%347.5M | -9.98%367.1M | 0.82%553.4M | -31.60%511.4M | -45.27%291.2M | -9.98%367.1M | -25.16%407.8M | 5.17%548.9M |
| Current changes in cash | 163.94%87.1M | -147.39%-105.1M | 48.84%-37.4M | 68.20%-13.1M | -5.07%-194.8M | 116.98%33M | 2.92%221.8M | -159.43%-73.1M | 47.98%-41.2M | -81.23%-185.4M |
| Effect of exchange rate changes | -62.22%3.4M | 747.37%12.3M | 332.14%6.5M | -638.46%-7M | -413.89%-11.3M | 300.00%9M | -2,000.00%-1.9M | -233.33%-2.8M | 107.60%1.3M | -76.47%3.6M |
| Cash adjustments other than cash changes | --0 | --0 | ---- | 162.50%500K | --200K | --0 | --300K | --0 | 98.04%-800K | --0 |
| End cash Position | -43.21%314.3M | -56.24%223.8M | 8.72%316.6M | -5.34%347.5M | -5.34%347.5M | 0.82%553.4M | -31.60%511.4M | -45.27%291.2M | -9.98%367.1M | -9.98%367.1M |
| Free cash from | 519.36%214.3M | 139.72%5.6M | 112.40%9.4M | 90.17%-73.6M | 89.97%-18.3M | 117.95%34.6M | 92.48%-14.1M | 59.31%-75.8M | -122.98%-749M | -50.33%-182.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.